newsfilter
← Latest News
Business Wire·

Fulgent Shares Preliminary Data from Poster Presentation at ESMO 2025 Conference

Fulgent Genetics, Inc. (NASDAQ:FLGT) ("Fulgent" or the "Company"), a technology-based company with a well-established clinical diagnostic business and a therapeutic development business, today announced preliminary